CRISPR-Cas9 DNA base-editing and prime-editing

A Kantor, ME McClements, RE MacLaren - International journal of …, 2020 - mdpi.com
Many genetic diseases and undesirable traits are due to base-pair alterations in genomic
DNA. Base-editing, the newest evolution of clustered regularly interspaced short palindromic …

Clinical perspective: treating RPE65-associated retinal dystrophy

AM Maguire, J Bennett, EM Aleman, BP Leroy… - Molecular Therapy, 2021 - cell.com
Until recently, there was no approved treatment for a retinal degenerative disease.
Subretinal injection of a recombinant adeno-associated virus (AAV) delivering the normal …

Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10

ML Maeder, M Stefanidakis, CJ Wilson, R Baral… - Nature medicine, 2019 - nature.com
Leber congenital amaurosis type 10 is a severe retinal dystrophy caused by mutations in the
CEP290 gene,. We developed EDIT-101, a candidate genome-editing therapeutic, to …

Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases

M Hanany, C Rivolta, D Sharon - Proceedings of the …, 2020 - National Acad Sciences
One of the major questions in human genetics is what percentage of individuals in the
general population carry a disease-causing mutation. Based on publicly available …

[HTML][HTML] Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom

N Pontikos, G Arno, N Jurkute, E Schiff, R Ba-Abbad… - Ophthalmology, 2020 - Elsevier
Purpose In a large cohort of molecularly characterized inherited retinal disease (IRD)
families, we investigated proportions with disease attributable to causative variants in each …

Pharmaceutical development of AAV-based gene therapy products for the eye

GA Rodrigues, E Shalaev, TK Karami… - Pharmaceutical …, 2019 - Springer
A resurgence of interest and investment in the field of gene therapy, driven in large part by
advances in viral vector technology, has recently culminated in United States Food and Drug …

[HTML][HTML] Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives

AV Garafalo, AV Cideciyan, E Héon, R Sheplock… - Progress in retinal and …, 2020 - Elsevier
Due to improved phenotyping and genetic characterization, the field of 'incurable'and
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …

[HTML][HTML] Stemming retinal regeneration with pluripotent stem cells

ZB Jin, ML Gao, WL Deng, KC Wu, S Sugita… - Progress in retinal and …, 2019 - Elsevier
Cell replacement therapy is a promising treatment for irreversible retinal cell death in diverse
diseases, such as age-related macular degeneration (AMD), Stargardt's disease, retinitis …

Clinical and genetic characteristics of 251 consecutive patients with macular and cone/cone-rod dystrophy

J Birtel, T Eisenberger, M Gliem, PL Müller… - Scientific reports, 2018 - nature.com
Macular and cone/cone-rod dystrophies (MD/CCRD) demonstrate a broad genetic and
phenotypic heterogeneity, with retinal alterations solely or predominantly involving the …

Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy

M Karali, F Testa, V Di Iorio, A Torella, R Zeuli… - Scientific Reports, 2022 - nature.com
Inherited retinal diseases (IRDs) are the leading cause of vision loss in the working-age
population. We performed a retrospective epidemiological study to determine the genetic …